A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

† Laboratory of Solid State Microstructures and Innovation Center of Advanced Microstructures, Nanjing University, Nanjing 210093, China § Institute for Advanced Materials and Laboratory of Quantum ...

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...

Background Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region. Seizures are frequently, but not always, associated with WHS.